What is the recommended dosing regimen for 262 mg chewable bismuth subsalicylate tablets in adults and adolescents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bismuth Subsalicylate 262 mg Chewable Tablets Dosing

For adults and adolescents 12 years and older, take 2 chewable tablets (524 mg) every 30-60 minutes or 4 chewable tablets (1,048 mg) every hour as needed for diarrhea, not exceeding 8 doses (16 tablets or 4,192 mg) in 24 hours, and do not use for more than 2 days. 1

Standard Dosing by Indication

For Acute Diarrhea

  • 2 tablets (524 mg) every 30 minutes to 1 hour as needed
  • Alternative: 4 tablets (1,048 mg) every hour as needed
  • Maximum: 8 doses (16 tablets total = 4,192 mg) in 24 hours
  • Duration: Do not exceed 2 days 1

For Upset Stomach, Heartburn, Indigestion, or Nausea

  • 2 tablets (524 mg) every 30 minutes to 1 hour as needed
  • Same maximum limits apply 1

For H. pylori Eradication (Bismuth Quadruple Therapy)

When used as part of H. pylori treatment regimens:

  • Bismuth ~300 mg four times daily (approximately 1 tablet per dose, though formulations vary)
  • Combined with metronidazole 500 mg three times daily, tetracycline 500 mg four times daily, and PPI twice daily
  • Duration: 14 days 2, 3

Critical Safety Considerations

Do not use in children under 12 years without physician guidance due to Reye's syndrome risk 1. The FDA labeling explicitly restricts use to those 12 years and older for self-medication.

Common Side Effects

  • Blackening of tongue and stools (benign and expected)
  • Constipation
  • Nausea 4, 5

Serious Toxicity Risk

Chronic overuse can cause salicylate toxicity, presenting with confusion, tinnitus, hearing impairment, and falls, particularly in elderly patients 6. Each 262 mg tablet contains 123 mg of salicylate 1. Patients must strictly adhere to the 2-day maximum duration for self-treatment to avoid accumulation.

Drug Interactions

Since bismuth subsalicylate contains salicylate, consider interactions with:

  • Anticoagulants (increased bleeding risk)
  • Other salicylate-containing products
  • Medications affected by salicylates

Clinical Pearls

Ensure adequate hydration during diarrheal illness to prevent dehydration 1. The short 2-day limit exists because persistent diarrhea requires medical evaluation for underlying causes.

For H. pylori treatment, bismuth quadruple therapy remains a recommended first-line option, particularly in penicillin allergy or areas with high clarithromycin resistance 2, 3. The dosing in this context is higher and longer (14 days) than for symptomatic diarrhea treatment.

Storage: Keep at temperatures not exceeding 25°C (77°F) and avoid excessive heat over 40°C 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.